Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
AstraZeneca PLC ADR
ISIN US0463531089
|WKN 886715
Market cap (in EUR)
240 863 M
Country
Grande-Bretagne
Sector
Santé
Dividend yield
1,66%
Overview
Description
AstraZeneca Plc est une société holding qui se consacre à la recherche, au développement, à la fabrication et à la commercialisation de médicaments sur ordonnance. La société a été fondée le 17 juin 1992 et son siège social se trouve à Cambridge, au Royaume-Uni.
Santé Produits biopharmaceutiques Autres produits biopharmaceutiques Grande-Bretagne
Financials
Key metrics
| Market capitalisation, EUR | 240 863 M |
| EPS, EUR | 2,75 |
| P/B ratio | 6,3 |
| P/E ratio | 30,5 |
| Dividend yield | 1,66% |
Income statement (2024)
| Revenue, EUR | 50 010 M |
| Net income, EUR | 6 506 M |
| Profit margin | 13,01% |
What ETF is AstraZeneca PLC ADR in?
There are 2 ETFs which contain AstraZeneca PLC ADR. All of these ETFs are listed in the table below. The ETF with the largest weighting of AstraZeneca PLC ADR is the Leverage Shares -5x Short Nasdaq 100 ETP.
| ETF | Weight | Investment focus | Fund size (in m EUR) |
|---|---|---|---|
| Leverage Shares 5x Long Nasdaq 100 ETP | 0.38% | Equity United States Technology | 28 |
| Leverage Shares -5x Short Nasdaq 100 ETP | 0.38% | Equity United States Technology | 5 |
Latest articles
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.